Abbott Laboratories (BUE:ABT)
ARS 33725 350 (1.05%) Market Cap: 204.17 Til Enterprise Value: 211.79 Til PE Ratio: 35.37 PB Ratio: 5.07 GF Score: 87/100

Abbott Laboratories at JPMorgan Healthcare Conference Transcript

Jan 11, 2022 / 02:00PM GMT
Release Date Price: ARS7150 (-1.19%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good morning, everyone. Happy to kick off day 2 of the JPMorgan Healthcare Conference on the medtech track. I'm Robbie Marcus, the analyst here for medical devices.

Very happy to have Abbott as our next company. Robert Ford, the CEO, is going to do a little bit of a fireside chat with me. We're going to start off with a couple of questions from my end. And then I can -- feel free to ask questions online or send me, and I could do my best to ask as many as I can.

But Robert, I really appreciate you taking the time to be here and speak today.

Robert B. Ford
Abbott Laboratories - Chairman of the Board, President & CEO

Nice being with you virtually.

Questions & Answers

Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Yes. So let's start with everybody's favorite discussion, which is COVID testing. Abbott has been a leader here. Maybe give us your latest thoughts and update on the COVID

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot